CYPSX | RYVLX | CYPSX / RYVLX | |
Total Expense Ratio | 2.62 | 1.90 | 138% |
Annual Report Gross Expense Ratio | 2.62 | 2.01 | 130% |
Fund Existence | 21 years | 21 years | - |
Gain YTD | -11.512 | -0.777 | 1,481% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 15000 | 2500 | 600% |
Min. Initial Investment IRA | 15000 | N/A | - |
Net Assets | 24.8M | 1.13B | 2% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 19.68 | 2.61 | 754% |
Returns for 3 years | 70.19 | 151.60 | 46% |
Returns for 5 years | 32.71 | 158.16 | 21% |
Returns for 10 years | 107.66 | 601.20 | 18% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SMSAX | 9.72 | -0.03 | -0.31% |
SEI Multi Strategy Alternatives F (SIMT) | |||
THCVX | 26.40 | -0.26 | -0.98% |
Nuveen Large Cap Value Idx I | |||
JGECX | 12.39 | -0.13 | -1.04% |
JHancock Global Equity C | |||
FLRAX | 40.05 | -0.58 | -1.43% |
Nuveen Large Cap Select A | |||
LSSIX | 27.61 | -0.42 | -1.50% |
Loomis Sayles Small Cap Growth Instl |